A significant shift in Canadian drug policy has taken place, as the authorities permit the legalization of psilocybin hallucinogens for therapeutic applications. Before this, these substances were severely restricted, but a growing body of studies suggests they may offer benefits for mental health issues like depression. The new policy represents a